Company Filing History:
Years Active: 2010
Title: Paola Gilotta: Innovator in Pharmaceutical Stability
Introduction
Paola Gilotta is a notable inventor based in Monza, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable crystalline forms of compounds. Her work is essential for improving the manufacturing processes in the pharmaceutical industry.
Latest Patents
Paola holds a patent for a new crystalline form of Andolast disodium salt, specifically Form A. This form is triclinic and exhibits a thermal event at 98-112°C, melting with decomposition at approximately 400°C, as determined by Differential Scanning Calorimetry (DSC). Notably, Andolast disodium Form A is a non-hygroscopic solid, demonstrating remarkable stability under various humidity conditions. This stability is crucial for both chemical and pharmaceutical manufacturing processes, allowing for consistency and reproducibility in conditions that are more viable and cost-effective compared to those required for highly hygroscopic solids.
Career Highlights
Paola Gilotta has established herself as a key figure in her field through her innovative research and development efforts. Her work at Rottapharm Spa has positioned her as a leader in pharmaceutical stability, contributing to advancements that benefit both manufacturers and consumers.
Collaborations
Throughout her career, Paola has collaborated with esteemed colleagues, including Antonio Giordani and Antonino Santoro. These partnerships have fostered an environment of innovation and have led to significant advancements in their shared field.
Conclusion
Paola Gilotta's contributions to the pharmaceutical industry, particularly through her patent for Andolast disodium Form A, highlight her role as an innovator. Her work not only enhances manufacturing processes but also ensures the stability and efficacy of pharmaceutical products.